1-4 of 4
Gabriel Rabinovich, PhD
Close
Sort by
Journal Articles

High Intratumoral Galectin-1 Is Associated with Adverse Outcome in ALK-Negative, CD30-Positive Peripheral T-Cell Lymphomas

Johanne Marie Holst, MD, Maja Ludvigsen, MSc, PhD Ass.prof, Stephen Dutoit, Knud Bendix, Trine Lindhardt Plesner, Peter Noergaard, MD, Michael Boe Møller, Torben Steiniche, Gabriel Rabinovich, PhD, Francesco d'Amore, MD PhD, Martin Bjerregård Pedersen, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4079.
https://doi.org/10.1182/blood.V130.Suppl_1.4079.4079
Published: 2017
Journal Articles

Tumor Microenvironmental Features and Outcome in Post-Transplant Lymphoproliferative Disorder

Maja Ølholm Vase, MD, Eva Maksten, MDcal student, Knud Bendix, Stephen Jacques Hamilton-Dutoit, Claus Andersen, Michael B. Møller, MD DMSc, Søren Schwartz Sørensen, Bente Jespersen, MD, Jan Kampmann, Gabriel Rabinovich, PhD, Esben Søndergård, Patricia Switten Nielsen, Francesco d'Amore
Journal: Blood
Blood (2014) 124 (21): 1617.
https://doi.org/10.1182/blood.V124.21.1617.1617
Published: 2014
Journal Articles

Galectin-1 Serum Levels Reflect Tumor Burden and Adverse Clinical Features in Hodgkin Lymphoma

Jing Ouyang, PhD, Annette Plütschow, PhD, Elke Pogge, PhD, Sabine Ponader, PhD, Gabriel Rabinovich, PhD, Donna S. Neuberg, ScD, Andreas Engert, MD, Margaret A. Shipp, MD
Journal: Blood
Blood (2012) 120 (21): 51.
https://doi.org/10.1182/blood.V120.21.51.51
Published: 2012
Journal Articles

Expression and Targeted Inhibition of the Immunoregulatory Carbohydrate-Binding Lectin, Galectin 1, in EBV-Driven Post-Transplant Lymphoproliferative Disorders.

Jing Ouyang, PhD, Przemyslaw Juszczynski, MD, PhD, Evan O'Donnell, Myriam Armant, PhD, Scott J. Rodig, MD, PhD, Kunihiko Takeyama, MD, PhD, Stefano Monti, PhD, Gabriel Rabinovich, PhD, Jeffery Lorne Kutok, MD, PhD, Jerome Ritz, MD, Margaret A. Shipp, MD
Journal: Blood
Blood (2009) 114 (22): 96.
https://doi.org/10.1182/blood.V114.22.96.96
Published: 2009